Search Results - "Lim, Z.Y."

Refine Results
  1. 1

    Sound absorption performance of natural kenaf fibres by Lim, Z.Y., Putra, A., Nor, M.J.M., Yaakob, M.Y.

    Published in Applied acoustics (15-01-2018)
    “…In recent years, kenaf fibre has been highlighted for its superiority as the filler for composite materials. However, study of the fibres as an acoustic…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis by Nagi, W, Lim, Z.Y, Krishnamurthy, P, Potter, V, Tindell, V, Reiff-Zall, L, Abdullah, A, Lea, N, Kenyon, M, Marsh, J, Ho, A.Y.L, Mufti, G.J, Pagliuca, A

    Published in Leukemia research (01-08-2011)
    “…Abstract We report the results of 11 patients myelofibrosis, who have received a uniform alemtuzumab-based RIC HSCT. The median recipient age was 51 years…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience by Krishnamurthy, P, Lim, Z Y, Nagi, W, Kenyon, M, Mijovic, A, Ireland, R, Marsh, J, Ho, A Y L, Mufti, G J, Pagliuca, A

    Published in Bone marrow transplantation (Basingstoke) (01-10-2010)
    “…Haematopoietic SCT (HSCT) offers the only potentially curative option in chronic myelomonocytic leukaemia (CMML). In this study, we report on single-centre…”
    Get full text
    Journal Article
  10. 10

    Isolation and identification of phosphatidic acid targets from plants by Testerink, C, Dekker, H.L, Lim, Z.Y, Johns, M.K, Holmes, A.B, Koster, C.G. de, Ktistakis, N.T, Munnik, T

    “…Phosphatidic acid (PA) is emerging as an important lipid signalling molecule. In plants, it is implicated in various stress-signalling pathways and is formed…”
    Get full text
    Journal Article
  11. 11

    Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML by Lim, Z Y, Ingram, W, Brand, R, Ho, A, Kenyon, M, Devereux, S, Marsh, J, Mufti, G J, Pagliuca, A

    Published in Bone marrow transplantation (Basingstoke) (01-04-2010)
    “…We report a retrospective analysis of 128 consecutive patients with high-risk myelodysplastic syndrome (MDS) and AML who received an alemtuzumab-based…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab by Moses, S.E., Lim, Z.Y., Sudhanva, M., Devereux, S., Ho, A.Y.L., Pagliuca, A., Zuckerman, M., Mufti, G.J.

    Published in Journal of medical virology (01-12-2006)
    “…Individuals with past exposure to hepatitis B virus (HBV) may reactivate HBV following bone marrow transplantation. Alemtuzumab (CAMPATH)‐based reduced…”
    Get full text
    Journal Article
  14. 14

    Haemophagocytic Lymphohistiocytosis Post Liver Transplantation by Barnardo, Adrian, Lim, Z.Y., Foxton, Matthew, Ramasamy, K., Mufti, Ghulam

    Published in Blood (16-11-2004)
    “…Haemophagocytic syndromes are rare but often-fatal conditions characterised by an inappropriate and sustained activation of the cellular immune system leading…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Precooling via immersion in CO2-enriched water at 25°C decreased core body temperature but did not improve 10-km cycling time trial in the heat by Aidiel, Luthfil, Lim, Darren Z. Y., Chow, Kin M., Ihsan, Mohammed, Chia, Michael, Choo, Hui C.

    Published in Temperature (Austin) (2024)
    “…This study compared the effects of precooling via whole-body immersion in 25°C CO 2 -enriched water (CO 2 WI), 25°C unenriched water (WI) or no cooling (CON)…”
    Get full text
    Journal Article